Reardon Andrew
Ligand Pharmaceuticals Incorporated - Common Stock · CLO & Secretary
Reardon Andrew is listed in filings as CLO & Secretary at Ligand Pharmaceuticals Incorporated - Common Stock. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Ligand Pharmaceuticals Incorporated - Common Stock (LGND). The current snapshot covers public activity from Jul 2, 2024 to Jun 2, 2026. Reported amounts are shown as $323.6K to $261.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $324k1.4k shares | SellJun 1, 2026 | $225.97 | $293.99 | |
| $279k1.2k shares | SellJun 1, 2026 | $229.47 | $293.99 | |
| $152k677 shares | SellJun 1, 2026 | $225.20 | $293.99 | |
| $133k584 shares | SellJun 1, 2026 | $228.57 | $293.99 | |
| $110k491 shares | SellJun 1, 2026 | $223.95 | $293.99 | |
| $91k400 shares | SellJun 1, 2026 | $226.78 | $293.99 | |
| $46k200 shares | SellJun 1, 2026 | $230.41 | $293.99 |